Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
REGENXBIO Inc. - Common Stock
(NQ:
RGNX
)
7.420
-0.110 (-1.46%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,705,151
Open
7.520
Bid (Size)
7.360 (200)
Ask (Size)
8.930 (100)
Prev. Close
7.530
Today's Range
7.300 - 7.736
52wk Range
5.455 - 16.19
Shares Outstanding
43,466,186
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)
August 25, 2026
From
Johnson Fistel, PLLP
Via
Business Wire
Top movers in Monday's session
↗
August 24, 2026
Via
Chartmill
Performance
YTD
-45.3%
-45.3%
1 Month
-20.4%
-20.4%
3 Month
-44.1%
-44.1%
6 Month
-13.0%
-13.0%
1 Year
-24.1%
-24.1%
More News
Read More
Which stocks are experiencing notable movement on Monday?
↗
August 24, 2026
Via
Chartmill
Monday's session: gap up and gap down stocks
↗
August 24, 2026
Via
Chartmill
REGENXBIO (NASDAQ:RGNX) Beats Q2 EPS but Misses Revenue; Duchenne Gene Therapy Timeline Reaffirmed
↗
August 06, 2026
Via
Chartmill
REGENXBIO INC (NASDAQ:RGNX) Plunges 17% on Q1 Revenue Miss Despite Positive DMD Gene Therapy Trial Results
↗
May 14, 2026
Via
Chartmill
Monday's pre-market session: top gainers and losers
↗
August 24, 2026
Via
Chartmill
REGENXBIO Q2 Earnings Call Highlights
↗
August 07, 2026
Via
MarketBeat
Topics
Earnings
The market is filled with gapping stocks in Friday's session.
↗
July 17, 2026
Via
Chartmill
What's going on in today's pre-market session
↗
July 17, 2026
Via
Chartmill
Thursday's after hours session: top gainers and losers
↗
July 16, 2026
Via
Chartmill
Regenxbio (RGNX) Q1 2026 Earnings Transcript
↗
May 18, 2026
Via
The Motley Fool
These stocks are moving in today's session
↗
May 14, 2026
Via
Chartmill
What's going on in today's session
↗
May 14, 2026
Via
Chartmill
Which stocks are gapping on Thursday?
↗
May 14, 2026
Via
Chartmill
Discover the top movers in Thursday's pre-market session.
↗
May 14, 2026
Via
Chartmill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX
April 14, 2026
From
Pomerantz LLP
Via
GlobeNewswire
RGNX Deadline Today: Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
April 14, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026
April 14, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 13, 2026
From
Schall Law
Via
GlobeNewswire
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 09, 2026
From
Schall Law
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX
April 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 06, 2026
From
Schall Law
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
April 05, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
April 04, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Frequently Asked Questions
Is REGENXBIO Inc. - Common Stock publicly traded?
Yes, REGENXBIO Inc. - Common Stock is publicly traded.
What exchange does REGENXBIO Inc. - Common Stock trade on?
REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for REGENXBIO Inc. - Common Stock?
The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market
What is the current price of REGENXBIO Inc. - Common Stock?
The current price of REGENXBIO Inc. - Common Stock is 7.420
When was REGENXBIO Inc. - Common Stock last traded?
The last trade of REGENXBIO Inc. - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of REGENXBIO Inc. - Common Stock?
The market capitalization of REGENXBIO Inc. - Common Stock is 322.52M
How many shares of REGENXBIO Inc. - Common Stock are outstanding?
REGENXBIO Inc. - Common Stock has 323M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
